Drug Approval | March 09, 2023
Eugia Pharma receives USFDA approval for Lenalidomide Capsules
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
Subscribe To Our Newsletter & Stay Updated
